Olopatadine HCl 0.2%; oph soln; contains benzalkonium chloride. Eye pain, changes in vision, increased redness of the eye, itching worsens or lasts for >72hrs; discontinue and evaluate if develops.
If you are using the over-the-counter product to self-treat, read and follow all directions on the product package before using this medication. If you have any questions, consult your pharmacist ...
Alembic Pharmaceuticals announced that it has received Tentative Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Olopatadine Hydrochloride ...
If you are using the over-the-counter product to self-treat, read and follow all directions on the product package before using this medication. If you have any questions, consult your pharmacist ...